APA (7th ed.) Citation

Wang, X., Tirucherai, G., Marbury, T. C., Wang, J., Chang, M., Zhang, D., . . . Frost, C. (2016). Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis. Journal of clinical pharmacology, 56(5), 628-636. https://doi.org/10.1002/jcph.628

Chicago Style (17th ed.) Citation

Wang, Xiaoli, et al. "Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban in Subjects with End-stage Renal Disease on Hemodialysis." Journal of Clinical Pharmacology 56, no. 5 (2016): 628-636. https://doi.org/10.1002/jcph.628.

MLA (9th ed.) Citation

Wang, Xiaoli, et al. "Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban in Subjects with End-stage Renal Disease on Hemodialysis." Journal of Clinical Pharmacology, vol. 56, no. 5, 2016, pp. 628-636, https://doi.org/10.1002/jcph.628.